After treatment of progressive phase of PF, we were able to conclude that Casp‐GNMT could reverse PF at the phases of injury and progression to inhibit the migration of immune cells and activation of inflammatory responses through a synergistic strategy of diagnosis and treatment. The gene discussed is GNMT; the disease is pemphigus foliaceus.